Whitepaper: Drug shortages – why do they happen and how can we stop them?
Posted: 17 February 2020 | NSF | No comments yet
With 56 percent of U.S. health care providers reporting to have changed patient care or delayed therapy as a result of drug shortages, this white paper from NSF looks at the key reasons behind the issue and what you can do to stop it.
Related content from this organisation
Related topics
Biopharmaceuticals, Formulation, Manufacturing, QA/QC, Research & Development (R&D)